NO20060229L - Gaboxadol for behandling av depresjon og andre affektive lidelser - Google Patents
Gaboxadol for behandling av depresjon og andre affektive lidelserInfo
- Publication number
- NO20060229L NO20060229L NO20060229A NO20060229A NO20060229L NO 20060229 L NO20060229 L NO 20060229L NO 20060229 A NO20060229 A NO 20060229A NO 20060229 A NO20060229 A NO 20060229A NO 20060229 L NO20060229 L NO 20060229L
- Authority
- NO
- Norway
- Prior art keywords
- gaboxadol
- depression
- treatment
- affective disorders
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Den foreliggende oppfinnelse vedrører anvendelse av gaboxadol for fremstilling av en farmasøytisk sammensetning for behandling av depresjon. Videre vedrører den anvendelsen av gaboxadol for fremstillingen av en farmasøytisk sammensetning for anvendelse i kombinasjon med en serotonin- reopptaksinhibitor eller enhver annen forbindelse, som forårsaker en forhøyelse i nivået av ekstiacellulært serotonin.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200300956 | 2003-06-25 | ||
DKPA200400016 | 2004-01-07 | ||
PCT/DK2004/000459 WO2004112786A2 (en) | 2003-06-25 | 2004-06-25 | Gaboxadol for treating depression and other affective disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20060229L true NO20060229L (no) | 2006-01-16 |
Family
ID=58707228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060229A NO20060229L (no) | 2003-06-25 | 2006-01-16 | Gaboxadol for behandling av depresjon og andre affektive lidelser |
Country Status (10)
Country | Link |
---|---|
KR (1) | KR20060025192A (no) |
AR (1) | AR047550A1 (no) |
CA (2) | CA2692334A1 (no) |
CL (2) | CL2004001607A1 (no) |
EA (1) | EA200600101A1 (no) |
IS (1) | IS8138A (no) |
ME (2) | ME00030B (no) |
NO (1) | NO20060229L (no) |
RS (1) | RS20050911A (no) |
TW (1) | TW200509918A (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3883566A4 (en) | 2018-11-21 | 2022-09-07 | Certego Therapeutics Inc. | GABOXADOL FOR SUICIDE RISK REDUCTION AND RAPID DEPRESSION RELIEF |
US11597726B2 (en) | 2020-05-20 | 2023-03-07 | Certego Therapeutics Inc. | Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders |
-
2004
- 2004-06-15 TW TW093117156A patent/TW200509918A/zh unknown
- 2004-06-23 AR ARP040102200A patent/AR047550A1/es not_active Application Discontinuation
- 2004-06-24 CL CL200401607A patent/CL2004001607A1/es unknown
- 2004-06-25 CA CA2692334A patent/CA2692334A1/en not_active Abandoned
- 2004-06-25 EA EA200600101A patent/EA200600101A1/ru unknown
- 2004-06-25 KR KR1020057024823A patent/KR20060025192A/ko not_active Application Discontinuation
- 2004-06-25 RS YUP-2005/0911A patent/RS20050911A/sr unknown
- 2004-06-25 CA CA002529805A patent/CA2529805A1/en not_active Abandoned
- 2004-06-25 ME MEP-2008-19A patent/ME00030B/me unknown
- 2004-06-25 ME MEP-19/08A patent/MEP1908A/xx unknown
-
2005
- 2005-11-21 IS IS8138A patent/IS8138A/is unknown
-
2006
- 2006-01-16 NO NO20060229A patent/NO20060229L/no not_active Application Discontinuation
-
2010
- 2010-02-25 CL CL2010000166A patent/CL2010000166A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
TW200509918A (en) | 2005-03-16 |
AR047550A1 (es) | 2006-01-25 |
ME00030B (me) | 2010-06-10 |
CL2004001607A1 (es) | 2005-05-27 |
IS8138A (is) | 2005-11-21 |
CA2529805A1 (en) | 2004-12-29 |
KR20060025192A (ko) | 2006-03-20 |
RS20050911A (en) | 2007-08-03 |
CL2010000166A1 (es) | 2010-07-02 |
CA2692334A1 (en) | 2004-12-29 |
MEP1908A (xx) | 2010-02-10 |
EA200600101A1 (ru) | 2006-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20060242L (no) | Kombinasjonen av en serotonin-reopptaksinhibitor og agomelatin | |
EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
IL202106A0 (en) | Gaboxadol for treating depression and other affective disorders | |
NO20082026L (no) | Deazapuriner som er nyttige som inhibitorer for Janus-kinaser | |
EA201101190A1 (ru) | Фармацевтическая композиция, включающая линаглиптин и необязательно ингибитор sglt2, и ее применение | |
EA201370208A1 (ru) | Формы рифаксимина и их применение | |
EA200601553A1 (ru) | Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды | |
EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
EA200970337A1 (ru) | Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения | |
EA201101192A1 (ru) | Фармацевтическая композиция, включающая производные глюкопиранозилдифенилметана, фармацевтическая дозированная форма, содержащая указанные производные, способ их получения и применения для улучшения гликемического контроля у пациентов | |
NO20083501L (no) | Azaindoler som er anvendelige som inhibitorer for Janus-kinaser | |
EA200970581A1 (ru) | Кристаллическое твёрдое основание разагилина | |
EA201100138A1 (ru) | 4-феноксиметилпиперидины в качестве модуляторов активности gpr119 | |
NO20070081L (no) | Sulfamat og sulfamidderivater for behandling av epilepsi og relaterte sykdommer | |
EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
NO20060402L (no) | 3-amino choman og 2-aminotetralinderivater | |
DK1937669T3 (da) | Nye benzopyranderivater som kaliumkanalåbnere | |
BRPI0508254A (pt) | métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos | |
EA201070327A1 (ru) | Катехоламиновые производные и их пролекарства | |
EA200702253A1 (ru) | Фармацевтическая композиция | |
CL2008003231A1 (es) | Compuestos derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo sustituido, inhibidores selectivos de la recaptacion de serotonina; composicion farmaceutica; procedimiento de preparacion; utiles en el tratamiento y/o prevencion de la eyaculacion prematura. | |
NO20083751L (no) | Metoder for behandling av kognitive og andre sykdommer | |
NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
ATE440836T1 (de) | Verbindungen | |
ATE524463T1 (de) | 4-chromenonyl-1,4-dihydropyridincarbonitrile und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |